Details
Stereochemistry | ACHIRAL |
Molecular Formula | C21H25N3O3S |
Molecular Weight | 399.507 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(OCCOCCN1CCCCC1)N2C3=C(SC4=C2N=CC=C4)C=CC=C3
InChI
InChIKey=DTVJXCOMJLLMAK-UHFFFAOYSA-N
InChI=1S/C21H25N3O3S/c25-21(27-16-15-26-14-13-23-11-4-1-5-12-23)24-17-7-2-3-8-18(17)28-19-9-6-10-22-20(19)24/h2-3,6-10H,1,4-5,11-16H2
Molecular Formula | C21H25N3O3S |
Molecular Weight | 399.507 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
CNS Activity
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.drugbank.ca/drugs/DB08796 |
Primary | Theratuss Approved UsePipazethate is a centrally acting antitussive drug that also has bronchodilatory and local anesthetic activities. Launch Date1962 |
Doses
Dose | Population | Adverse events |
---|---|---|
40 mg/mL single, oral Overdose Dose: 40 mg/mL Route: oral Route: single Dose: 40 mg/mL Sources: |
healthy, 32 months n = 1 Health Status: healthy Age Group: 32 months Sex: F Population Size: 1 Sources: |
Other AEs: Tonic-clonic seizures, Coma... Other AEs: Tonic-clonic seizures (grade 5, 1 patient) Sources: Coma (grade 5, 1 patient) Respiratory insufficiency (grade 5, 1 patient) |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Coma | grade 5, 1 patient | 40 mg/mL single, oral Overdose Dose: 40 mg/mL Route: oral Route: single Dose: 40 mg/mL Sources: |
healthy, 32 months n = 1 Health Status: healthy Age Group: 32 months Sex: F Population Size: 1 Sources: |
Respiratory insufficiency | grade 5, 1 patient | 40 mg/mL single, oral Overdose Dose: 40 mg/mL Route: oral Route: single Dose: 40 mg/mL Sources: |
healthy, 32 months n = 1 Health Status: healthy Age Group: 32 months Sex: F Population Size: 1 Sources: |
Tonic-clonic seizures | grade 5, 1 patient | 40 mg/mL single, oral Overdose Dose: 40 mg/mL Route: oral Route: single Dose: 40 mg/mL Sources: |
healthy, 32 months n = 1 Health Status: healthy Age Group: 32 months Sex: F Population Size: 1 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Flow injection potentiometric determination of pipazethate hydrochloride. | 2001 Jan |
|
Spectrophotometric determination of some anti-tussive and anti-spasmodic drugs through ion-pair complex formation with thiocyanate and cobalt(II) or molybdenum(V). | 2007 Apr |
|
Spectrophotometric determination of pipazethate hydrochloride in pure form and in pharmaceutical formulations. | 2007 May-Jun |
|
Flow injection potentiometric assay of hexoprenaline in its pure state, pharmaceutical preparations, and biological samples. | 2008 |
|
Spectrophotometric determination of etodolac in pure form and pharmaceutical formulations. | 2008 Apr 14 |
|
Adverse drug effects in hospitalized elderly: data from the healthcare cost and utilization project. | 2010 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:01:44 GMT 2023
by
admin
on
Fri Dec 15 15:01:44 GMT 2023
|
Record UNII |
M5EK1T5V2L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Official Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
R05DB11
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
||
|
WHO-VATC |
QR05DB11
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
||
|
NCI_THESAURUS |
C66917
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000081981
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
PRIMARY | |||
|
PIPAZETATE
Created by
admin on Fri Dec 15 15:01:45 GMT 2023 , Edited by admin on Fri Dec 15 15:01:45 GMT 2023
|
PRIMARY | |||
|
C016064
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
PRIMARY | |||
|
2167-85-3
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
PRIMARY | |||
|
M5EK1T5V2L
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
PRIMARY | |||
|
DB08796
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
PRIMARY | |||
|
22425
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
PRIMARY | |||
|
m8839
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
PRIMARY | Merck Index | ||
|
C82252
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
PRIMARY | |||
|
218-508-8
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104900
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
PRIMARY | |||
|
1124
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
PRIMARY | |||
|
SUB09861MIG
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
PRIMARY | |||
|
2182
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
PRIMARY | |||
|
DTXSID40176056
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
PRIMARY | |||
|
33740
Created by
admin on Fri Dec 15 15:01:44 GMT 2023 , Edited by admin on Fri Dec 15 15:01:44 GMT 2023
|
PRIMARY | RxNorm |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |